CEACAM5 and breast carcinoma: At present, the representative tumor markers used for breast cancer diagnosis in clinical practice are cancer antigen 15-3 (CA15-3) and carcinoembryonic antigen (CEA); these are approved for breast cancer monitoring by the United States Food and Drug Administration [1,2,3].